Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10339225
United States Court of Appeals for the Fourth Circuit
Tigress McDaniel v. Sun Pharmaceutical Industries Ltd.
No. 10339225 · Decided February 24, 2025
No. 10339225·Fourth Circuit · 2025·
FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Fourth Circuit
Decided
February 24, 2025
Citation
No. 10339225
Disposition
See opinion text.
Full Opinion
USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 1 of 2
UNPUBLISHED
UNITED STATES COURT OF APPEALS
FOR THE FOURTH CIRCUIT
No. 24-2002
TIGRESS SYDNEY ACUTE MCDANIEL,
Plaintiff - Appellant,
v.
SUN PHARMACEUTICAL INDUSTRIES LTD.; SUN PHARMACEUTICAL
INDUSTRIES, INC.; SUN PHARMACEUTICAL MEDICARE LIMITED; CVS
PHARMACY, INC.; DOES,
Defendants - Appellees.
Appeal from the United States District Court for the Western District of North Carolina, at
Charlotte. Graham C. Mullen, Senior District Judge. (3:24-cv-00823-GCM)
Submitted: February 20, 2025 Decided: February 24, 2025
Before AGEE, HARRIS, and RUSHING, Circuit Judges.
Dismissed by unpublished per curiam opinion.
Tigress Sydney Acute McDaniel, Appellant Pro Se.
Unpublished opinions are not binding precedent in this circuit.
USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 2 of 2
PER CURIAM:
Tigress Sydney Acute McDaniel seeks to appeal the district court’s September 16,
2024, text order denying McDaniel’s motion to strike language from a prior court order.
This court may exercise jurisdiction only over final orders, 28 U.S.C. § 1291, and certain
interlocutory and collateral orders, 28 U.S.C. § 1292; Fed. R. Civ. P. 54(b); Cohen v.
Beneficial Indus. Loan Corp., 337 U.S. 541, 545-46 (1949). The order that McDaniel seeks
to appeal is neither a final order, given that litigation on her claims is ongoing, nor is it an
appealable interlocutory or collateral order. Accordingly, we dismiss this appeal for lack
of jurisdiction. We dispense with oral argument because the facts and legal contentions
are adequately presented in the materials before this court and argument would not aid the
decisional process.
DISMISSED
2
Plain English Summary
USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 1 of 2 UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No.
Key Points
01USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 1 of 2 UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No.
0224-2002 TIGRESS SYDNEY ACUTE MCDANIEL, Plaintiff - Appellant, v.
03SUN PHARMACEUTICAL INDUSTRIES LTD.; SUN PHARMACEUTICAL INDUSTRIES, INC.; SUN PHARMACEUTICAL MEDICARE LIMITED; CVS PHARMACY, INC.; DOES, Defendants - Appellees.
04(3:24-cv-00823-GCM) Submitted: February 20, 2025 Decided: February 24, 2025 Before AGEE, HARRIS, and RUSHING, Circuit Judges.
Frequently Asked Questions
USCA4 Appeal: 24-2002 Doc: 7 Filed: 02/24/2025 Pg: 1 of 2 UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No.
FlawCheck shows no negative treatment for Tigress McDaniel v. Sun Pharmaceutical Industries Ltd. in the current circuit citation data.
This case was decided on February 24, 2025.
Use the citation No. 10339225 and verify it against the official reporter before filing.